PrecisionGo is an MRFF-funded fully integrated, national precision medicine platform - streamlining design, execution, and translation, while also shaping the future of how precision medicine is delivered in Australia. The PrecisionGo Proof-of-Principle Trials is an opportunity for projects with existing funding to accelerate their projects through PrecisionGo’s integrated end-to-end pipelines with the advanced technologies across the integrated Westmead Research Hub core facilities (Histology, Genomics, Proteomics, Cytometry, Bioresources, Imaging, Biobanking, and Bioinformatics) and digital platform. The purpose of these trials is to:

Demonstrate feasibility of running integrated, end-to-end precision medicine projects
Test coordinated use of multiple scientific platforms and digital infrastructure
Generate learning that strengthens national translational research capability

Successful applicants will receive In-kind support and access valued at up to $100,000 that includes:

Across 2027-2028, priority access to WRH Core Scientific Platforms services and technologies (instrument usage and equipment time, including discounted kits and reagents for PrecisionGo pipelines) across WRH Core Facilities (histology, genomics, proteomics, cytometry, imaging and biobanking) to a value of $30,000.
Structured use of the PrecisionGo Digital Platform for data integration, analysis, and reporting with dedicated technical expertise (includes up to $35,000 time across the 2 years each from dedicated Bioinformatician and dedicated Data Engineer)
Coordinated project oversight to support delivery, quality, and compliance
Visibility for project outcomes through PrecisionGo networks and communications

‍ ‍

Applications are welcomed by projects using any amount up to the $100,000 value.

By taking part, you will not only advance your own research but also help refine and optimise PrecisionGo’s integrated model, shaping how integrated infrastructure can overcome the fragmentation, delays, and inconsistencies often encountered in precision medicine research.

Please submit this completed application by emailing a completed form and all related attachments to precisiongo@wimr.org.au by the closing date: 11:59 pm (AEST) on Wednesday 30 September, 2026. Late submissions will not be accepted.

Email precisiongo@wimr.org.au for enquiries or questions.

Additional resources, including detailed descriptions of the Pr ecisionGo end-to-end pi peli nes, are available on the PrecisionGo website (see 'Capabilities’ page).

To be eligible for this grant, the project must:

Have a Chief Investigator affiliated with an Australian Not-for-Profit organisation (such as a University, Medical Research Institute, health facility, etc.)
Use at least one of the PrecisionGo precision medicine pipelines (see PrecisionGo Capabilities page)
Use the PrecisionGo Digital Platform for analysis (see PrecisionGo Capabilities page) ‍
Be willing to share short project summarise and images for project promotion
Have obtained a valid ethics approval by November 2026
Complete and report on activities funded or supported by PrecisionGo grant by 31 December 2028 (further analysis, follow-on studies, or new experiments beyond this point outside of the scope of this grant)
Agree to acknowledge PrecisionGo, MRFF, Westmead Institute for Medical Research, and Westmead Research Hub Core Facilities in all resulting publications and presentations.
Agree to submit annual progress reports and a final report, and a short presentation at the Westmead Research Conference in 2028

Meaningful use and integration of PrecisionGo pipelines and facilities
Appropriate and effective use of the Digital Platform for data integration and analysis
Clarity and soundness of research question and study design appropriate to PoP scale
Credible pathway from PoP outcomes to clinical, translational, or system impact in precision medicine
Realistic timeline, milestones, risk identification (in dependencies) and mitigations
Budget realism, justification, and alignment with PoP objectives
Quality and appropriateness of consumer involvement in study

Applications Open: Wednesday 1 July 2026
Applications Close: 11:59pm Wednesday 30 September 2026. No extensions of time will be granted.
Final Selection Announced: December 2026
Projects Commence: January 2027

Applicants are responsible for submitting a complete and accurate application using the official PrecisionGo template and for ensuring that proposed milestones, timelines, risks, and budgets are realistic and achievable. Applicants must hold all required governance approvals prior to project commencement, including valid human research ethics approval, and must conduct all research in accordance with approved protocols, applicable legislation, and institutional policies relating to data privacy, security, and research integrity.
Applicants retain ownership of all background intellectual property brought into the project, including pre-existing data, samples, methods, software, and know-how, and confirm that they have the right to use such material within the proposed work. Intellectual property generated through the project remains with the investigators and their host institutions, consistent with institutional policies. Participation in the PrecisionGo Proof-of-Principle Trials does not transfer ownership of background or project-generated intellectual property. Intellectual property associated with the PrecisionGo Digital Platform, including code, workflows, and pipelines, remains with the contributing developers or organisations, and use of the platform does not confer ownership or commercial rights over these components.
Applicants are responsible for the ethical conduct of their research and for the lawful, accurate, and appropriate use of all data generated or uploaded to the PrecisionGo Digital Platform. PrecisionGo provides infrastructure, technical expertise, and coordinated project support but does not assume liability for research conduct, outcomes, or downstream use of results. Applicants confirm that their institution holds appropriate insurance and indemnity coverage for the proposed research activities.
Participation in the PrecisionGo Proof-of-Principle Trials is at the applicant’s own risk. PrecisionGo, Westmead Institute for Medical Research, and participating core facilities do not accept liability for the conduct of the research, research outcomes, data integrity, or any downstream clinical, regulatory, or commercial use of project outputs. Applicants remain responsible for their research activities and confirm that their host institution holds appropriate insurance and indemnity arrangements for the proposed work.
Applicants agree to acknowledge PrecisionGo, MRFF, Westmead Institute for Medical Research and the Westmead Research Hub Core Facilities in all resulting publications and presentations, to participate in required reporting and evaluation activities, and to share high-level project summaries and images for communication and program learning purposes. PrecisionGo reserves the right to withdraw support in the event of material non-compliance with these responsibilities.

PrecisionGo Proof of Principle Trials